Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1984 4
1989 1
1990 3
1991 8
1992 1
1993 1
1996 7
1997 3
1998 3
1999 2
2000 4
2001 1
2002 1
2003 4
2004 6
2005 6
2006 3
2007 7
2008 6
2009 6
2010 3
2011 6
2012 7
2013 6
2014 5
2015 8
2016 9
2017 3
2018 10
2019 9
2020 7
2021 5
2022 13
Text availability
Article attribute
Article type
Publication date

Search Results

161 results
Results by year
Filters applied: . Clear all
Page 1
Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease.
Sabbagh M, Sadowsky C, Tousi B, Agronin ME, Alva G, Armon C, Bernick C, Keegan AP, Karantzoulis S, Baror E, Ploznik M, Pascual-Leone A. Sabbagh M, et al. Among authors: armon c. Alzheimers Dement. 2020 Apr;16(4):641-650. doi: 10.1016/j.jalz.2019.08.197. Epub 2020 Jan 16. Alzheimers Dement. 2020. PMID: 31879235 Clinical Trial.
Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary: Report of the AAN Guideline Subcommittee.
Price R, Smith D, Franklin G, Gronseth G, Pignone M, David WS, Armon C, Perkins BA, Bril V, Rae-Grant A, Halperin J, Licking N, O'Brien MD, Wessels SR, MacGregor LC, Fink K, Harkless LB, Colbert L, Callaghan BC. Price R, et al. Among authors: armon c. Neurology. 2022 Jan 4;98(1):31-43. doi: 10.1212/WNL.0000000000013038. Neurology. 2022. PMID: 34965987
ALSUntangled #64: butyrates.
Sun Y, Bedlack R, Armon C, Beauchamp M, Bertorini T, Bowser R, Bromberg M, Caress J, Carter G, Crayle J, Cudkowicz ME, Glass JD, Jackson C, Lund I, Martin S, Paganoni S, Pattee G, Ratner D, Salmon K, Wicks P. Sun Y, et al. Among authors: armon c. Amyotroph Lateral Scler Frontotemporal Degener. 2022 Nov;23(7-8):638-643. doi: 10.1080/21678421.2022.2045323. Epub 2022 Feb 28. Amyotroph Lateral Scler Frontotemporal Degener. 2022. PMID: 35225121 Review.
ALSUntangled #67: rituximab.
Li X, Armon C, Barkhaus P, Barnes B, Benatar M, Bertorini T, Bromberg M, Carter GT, Crayle J, Cudkowicz M, Dimachkie M, Feldman EL, Glass J, Goslinga J, Heiman-Patterson T, Jhooty S, Lichtenstein R, Lund I, Mcdermott C, Pattee G, Pierce K, Ratner D, Salmon K, Wicks P, Bedlack R. Li X, et al. Among authors: armon c. Amyotroph Lateral Scler Frontotemporal Degener. 2022 Sep 15:1-4. doi: 10.1080/21678421.2022.2122845. Online ahead of print. Amyotroph Lateral Scler Frontotemporal Degener. 2022. PMID: 36106861 Review.
A blow to the head trauma--ALS hypothesis.
Armon C, Albert SM. Armon C, et al. Neurology. 2015 Apr 28;84(17):1728-9. doi: 10.1212/WNL.0000000000001528. Epub 2015 Apr 1. Neurology. 2015. PMID: 25832659 No abstract available.
Short- and long-term outcome and predictors in an international cohort of patients with neuro-COVID-19.
Beghi E, Helbok R, Ozturk S, Karadas O, Lisnic V, Grosu O, Kovács T, Dobronyi L, Bereczki D, Cotelli MS, Turla M, Davidescu EI, Popescu BO, Valzania F, Cavallieri F, Ulmer H, Maia LF, Amodt AH, Armon C, Brola W, Victoria G, Riahi A, Krehan I, von Oertzen T, Azab MA, Crean M, Lolich M, Lima MJ, Sellner J, Perneczky J, Jenkins T, Meoni S, Bianchi E, Moro E, Bassetti CLA; ENERGY Study Group. Beghi E, et al. Among authors: armon c. Eur J Neurol. 2022 Jun;29(6):1663-1684. doi: 10.1111/ene.15293. Epub 2022 Mar 7. Eur J Neurol. 2022. PMID: 35194889 Free PMC article.
ALS Untangled No. 20: the Deanna protocol.
ALSUntangled Group, Fournier C, Bedlack B, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Ostrow L, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, Dimachkie M, Wang Y, Wicks P, Heywood J, Novella S, Rowland LP, Pioro E, Kinsley L, Mitchell K, Glass J, Sathornsumetee S, Kwiecinski H, Baker J, Atassi N, Forshew D, Ravits J, Conwit R, Jackson C, Sherman A, Dalton K, Tindall K, Gonzalez G, Robertson J, Phillips L, Benatar M, Sorenson E, Shoesmith C, Nash S, Maragakis N, Moore D, Caress J, Boylan K, Armon C, Grosso M, Gerecke B, Wymer J, Oskarsson B, Bowser R, Drory V, Shefner J, Lechtzin N, Leitner M, Miller R, Mitsumoto H, Levine T, Russell J, Sharma K, Saperstein D, McClusky L, MacGowan D, Licht J, Verma A, Strong M, Lomen-Hoerth C, Tandan R, Rivner M, Kolb S, Polak M, Rudnicki S, Kittrell P, Quereshi M, Sachs G, Pattee G, Weiss M, Kissel J, Goldstein J, Rothstein J, Pastula D, Gleb L, Ogino M, Rosenfeld J, Carmi E, Oster C, Barkhaus P, Valor E. ALSUntangled Group, et al. Among authors: armon c. Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14(4):319-23. doi: 10.3109/21678421.2013.788405. Epub 2013 May 2. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23638638 Review. No abstract available.
Theme 1 Epidemiology and informatics.
Armon C. Armon C. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(sup1):101-113. doi: 10.1080/21678421.2019.1646989. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 31702469
161 results